載入...
Prime time for immune-checkpoint targeted therapy at ASCO 2015
Cancer immunotherapy has been one of the dominant topics in oral presentations and abstracts during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO). The renewed interest in immunotherapy is explained by the wide spectrum of activity, the durability of tumor responses and...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839368/ https://ncbi.nlm.nih.gov/pubmed/27141332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1068494 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|